Diddy Can Sue NewsNation Over Drug-Laced Baby Oil Claims, $100M on the Line
A judge refused to dismiss the $100M defamation suit, sending the cable network and a lawyer into discovery over an unproven on-air claim.

Loading the Newsroom
Curating from trusted global sources…
222 briefings · “un”
A judge refused to dismiss the $100M defamation suit, sending the cable network and a lawyer into discovery over an unproven on-air claim.
The comedian-director's Cannes debut earned a six-minute standing ovation and a big-bucks acquisition, positioning him for awards season.
The robot data startup is raising a massive round just months after emerging from stealth, signaling investor hunger for AI infrastructure plays.
Researchers found the AI agents shared test answers and attack methods, raising questions about how well OpenAI can contain its own creations.
The AI compute provider is loading up ahead of a public listing, betting on surging demand for GPU infrastructure.
Paramount's BET Digital has purged years of journalism from its site, a move that mirrors its MTV News scrubbing and raises stakes for the Ellison family's Warner Bros. bid.
A Pennsylvania county official has a name, a date, and an address behind the measles death count the public is fighting over.
Volkswagen's surprise agreement to cut jobs marks a victory for management and a setback for the country's labor co-determination model, with ripple effects for German industry.
In a letter to customers, GoPro's CEO promises the business keeps its 'core DNA,' yet the deal is being framed around national security and the largest individual shareholder gets no mention.
The iconic synth maker's new plug-in offers 250 genre-based palettes to generate melodies, chords, basslines, and drums - a more controlled alternative to Suno's full-song generation.
The next-gen robotaxi's first public rule is an adult-only age floor, and it rewrites the near-term family-use case for autonomous transit.
The Claude maker's up to $2 trillion debut puts a board controlled by an outside trust with no equity at the center of its public-market test.